Coq10 and Viibryd drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Coq10 (coenzyme q - 10) and Viibryd (vilazodone hydrochloride). Common drug interactions include migraine among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Coq10 and Viibryd. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Coq10?

Coq10 has active ingredients of coenzyme q - 10. It is often used in high blood cholesterol. eHealthMe is studying from 10,401 Coq10 users. Check the latest studies of Coq10.

What is Viibryd?

Viibryd has active ingredients of vilazodone hydrochloride. It is often used in depression. eHealthMe is studying from 11,106 Viibryd users. Check the latest studies of Viibryd.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

24 people who take Coq10 and Viibryd together, and have interactions are studied.

What are the common drug interactions of Coq10 and Viibryd, by gender? *:

female:

Migraine (headache)
Muscle twitching
Pruritus (severe itching of the skin)
Agitation (state of anxiety or nervous excitement)
Apathy
Arthralgia (joint pain)
Asthenia (weakness)
Decreased appetite
Diarrhoea
Drug ineffective

male:

Dizziness
Balance disorder
Corneal dystrophy (abnormal deposition of substances in the transparent front part of the eye)
Cough
Device failure
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Headache (pain in head)
Heart rate irregular
Influenza like illness

What are the common drug interactions of Coq10 and Viibryd, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Pruritus (severe itching of the skin)
Agitation (state of anxiety or nervous excitement)
Arthralgia (joint pain)
Corneal dystrophy (abnormal deposition of substances in the transparent front part of the eye)
Decreased appetite
Dysarthria (speech disorder)
Dysphagia (a condition in which swallowing is difficult or painful)
Gait disturbance
Hypersensitivity
Irritability

50-59:

n/a

60+:

Balance disorder
Derealisation
Asthenia (weakness)
Cough
Device failure
Headache (pain in head)
Influenza like illness
Migraine (headache)
Muscular weakness (muscle weakness)
Nervousness

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 29.17%
Parkinson's Disease: 5 people, 20.83%
Migraine (headache): 5 people, 20.83%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 20.83%
Hypersensitivity: 3 people, 12.50%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 12.50%
Nausea (feeling of having an urge to vomit): 2 people, 8.33%
Muscle Twitching: 2 people, 8.33%
Hallucinations (sensations that appear real but are created by your mind): 2 people, 8.33%
Delusion (a false belief or opinion): 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Coq10 and Viibryd?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously